These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 3844465)

  • 21. Studies of the kallikrein-kinin system in patients with sickle cell anemia.
    Miller RL; Verma PS; Adams RG
    J Natl Med Assoc; 1983 Jun; 75(6):551-6. PubMed ID: 6603519
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Kininogen deficiency in Fitzgerald trait: role of high molecular weight kininogen in clotting and fibrinolysis.
    Donaldson VH; Glueck HI; Miller MA; Movat HZ; Habal F
    J Lab Clin Med; 1976 Feb; 87(2):327-37. PubMed ID: 1245795
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhanced specificity of immunoblotting using radiolabeled antigen overlay: studies of blood coagulation factor XII and prekallikrein in plasma.
    Lämmle B; Berrettini M; Griffin JH
    Anal Biochem; 1986 Jul; 156(1):118-25. PubMed ID: 3638135
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interactions among Hageman factor, plasma prekallikrein, high molecular weight kininogen, and plasma thromboplastin antecedent.
    Ratnoff OD; Saito H
    Proc Natl Acad Sci U S A; 1979 Feb; 76(2):958-61. PubMed ID: 284420
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of prekallikrein and high-molecular-weight kininogen as a complex in human plasma.
    Mandle RJ; Colman RW; Kaplan AP
    Proc Natl Acad Sci U S A; 1976 Nov; 73(11):4179-83. PubMed ID: 1069308
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of Hageman factor, prekallifrein, and high molecular weight kininogen in the generation of bradykinin and the initiation of coagulation and fibrinolysis.
    Kaplan AP; Meier HL; Mandle RJ
    Monogr Allergy; 1977; 12():120-30. PubMed ID: 335210
    [No Abstract]   [Full Text] [Related]  

  • 27. Reduced plasma kininogen concentration during sickle cell crisis.
    Verma PS; Adams RG; Miller RL
    Res Commun Chem Pathol Pharmacol; 1983 Aug; 41(2):313-22. PubMed ID: 6635322
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tachibana trait: human high molecular weight kininogen deficiency with diminished levels of prekallikrein and low molecular weight kininogen.
    Nakamura K; Iijima K; Fukuda C; Kadowaki H; Ikoma H; Oh-ishi S; Uchida Y; Katori M
    Nihon Ketsueki Gakkai Zasshi; 1985 Sep; 48(6):1473-9. PubMed ID: 3853954
    [No Abstract]   [Full Text] [Related]  

  • 29. Mechanisms for the involvement of high molecular weight kininogen in surface-dependent reactions of Hageman factor.
    Griffin JH; Cochrane CG
    Proc Natl Acad Sci U S A; 1976 Aug; 73(8):2554-8. PubMed ID: 1066663
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The binding and cleavage characteristics of human Hageman factor during contact activation. A comparison of normal plasma with plasmas deficient in factor XI, prekallikrein, or high molecular weight kininogen.
    Revak SD; Cochrane CG; Griffin JH
    J Clin Invest; 1977 Jun; 59(6):1167-75. PubMed ID: 864009
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activation and function of human Hageman factor. The role of high molecular weight kininogen and prekallikrein.
    Meier HL; Pierce JV; Colman RW; Kaplan AP
    J Clin Invest; 1977 Jul; 60(1):18-31. PubMed ID: 874082
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mechanism of activation of the kallikrein-kinin system in plasma of patients with atopic allergic diseases.
    Dotsenko VL; Nenasheva NM; Neshkova EA; Morozova NA; Yarovaya GA
    Adv Exp Med Biol; 1989; 247B():515-21. PubMed ID: 2610090
    [No Abstract]   [Full Text] [Related]  

  • 33. Immunoblotting studies of coagulation factor XII, plasma prekallikrein, and high molecular weight kininogen.
    Lämmle B; Berrettini M; Griffin JH
    Semin Thromb Hemost; 1987 Jan; 13(1):106-14. PubMed ID: 3494310
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human plasma prekallikrein and high molecular weight kininogen decrease during parturition.
    Alving BM; Niebyl JR; Proud D; Mason BL; Pisano JJ
    Thromb Res; 1984 Jun; 34(6):473-7. PubMed ID: 6564799
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Kinetic studies on surface-mediated activation of bovine factor XII and prekallikrein. Effects of kaolin and high-Mr kininogen on the activation reactions.
    Sugo T; Kato H; Iwanaga S; Takada K; Sakakibara S
    Eur J Biochem; 1985 Jan; 146(1):43-50. PubMed ID: 3871394
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activation of intrinsic coagulation pathway in pre-eclampsia.
    Vaziri ND; Toohey J; Powers D; Keegan K; Gupta A; Alikhani S; Mashood M; Barbari A
    Am J Med; 1986 Jan; 80(1):103-7. PubMed ID: 3079949
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Factor XII-mediated contact activation related to poor prognosis in disseminated intravascular coagulation.
    Park HS; Gu J; You HJ; Kim JE; Kim HK
    Thromb Res; 2016 Feb; 138():103-107. PubMed ID: 26706311
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activation of surface-bound Hageman factor: pre-eminent role of high molecular weight kininogen and evidence for a new factor.
    Webster ME; Guimaraes JA; Kaplan AP; Colman RW; Pierce JV
    Adv Exp Med Biol; 1976; 70(00):285-99. PubMed ID: 937135
    [No Abstract]   [Full Text] [Related]  

  • 39. Molecular assembly in the contact phase of the Hageman factor system.
    Cochrane CG; Griffin JH
    Am J Med; 1979 Oct; 67(4):657-64. PubMed ID: 386794
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Studies on plasma prekallikrein assay method with chromogenic substrates (S-2302)].
    Fukuda C; Iijima K; Nakamura K
    Rinsho Byori; 1983 Feb; 31(2):219-22. PubMed ID: 6190027
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.